Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 29% ± 12% | |
platelet | 6 studies | 21% ± 5% | |
fibroblast | 4 studies | 23% ± 7% | |
epithelial cell | 4 studies | 36% ± 10% | |
endothelial cell | 4 studies | 24% ± 3% | |
macrophage | 4 studies | 19% ± 3% | |
basal cell | 4 studies | 22% ± 3% | |
placental villous trophoblast | 3 studies | 34% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 3723.34 | 170 / 170 | 100% | 71.27 | 459 / 459 |
skin | 100% | 7757.48 | 1808 / 1809 | 100% | 78.44 | 472 / 472 |
breast | 100% | 3746.86 | 459 / 459 | 100% | 91.00 | 1113 / 1118 |
thymus | 100% | 3373.20 | 650 / 653 | 100% | 47.89 | 603 / 605 |
kidney | 100% | 3143.34 | 89 / 89 | 99% | 41.42 | 893 / 901 |
prostate | 100% | 3501.27 | 244 / 245 | 99% | 50.06 | 499 / 502 |
ovary | 100% | 3467.99 | 180 / 180 | 99% | 33.93 | 425 / 430 |
lung | 99% | 3649.23 | 575 / 578 | 99% | 52.95 | 1141 / 1155 |
bladder | 100% | 4809.43 | 21 / 21 | 98% | 61.14 | 495 / 504 |
liver | 98% | 2029.32 | 222 / 226 | 100% | 50.20 | 405 / 406 |
esophagus | 100% | 3881.93 | 1444 / 1445 | 97% | 30.85 | 178 / 183 |
pancreas | 98% | 2078.00 | 320 / 328 | 99% | 38.98 | 177 / 178 |
adrenal gland | 100% | 4610.22 | 258 / 258 | 95% | 69.19 | 218 / 230 |
intestine | 100% | 2723.17 | 962 / 966 | 94% | 20.84 | 495 / 527 |
brain | 96% | 2147.06 | 2530 / 2642 | 98% | 40.69 | 689 / 705 |
stomach | 100% | 5814.53 | 359 / 359 | 92% | 20.31 | 262 / 286 |
eye | 0% | 0 | 0 / 0 | 100% | 85.83 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.26 | 29 / 29 |
muscle | 100% | 26573.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3601.55 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.58 | 1 / 1 |
adipose | 100% | 3197.52 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4233.30 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 6160.65 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 68.99 | 44 / 45 |
peripheral blood | 84% | 2037.50 | 779 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016126 | Biological process | sterol biosynthetic process |
GO_0015701 | Biological process | bicarbonate transport |
GO_0031092 | Cellular component | platelet alpha granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0071949 | Molecular function | FAD binding |
GO_0004128 | Molecular function | cytochrome-b5 reductase activity, acting on NAD(P)H |
GO_0005515 | Molecular function | protein binding |
Gene name | CYB5R1 |
Protein name | cytochrome-b5 reductase (EC 1.6.2.2) NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2) |
Synonyms | UNQ3049/PRO9865 NQO3A2 |
Description | FUNCTION: NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction. . |
Accessions | ENST00000446185.1 H7C0R7 ENST00000367249.9 Q9UHQ9 |